Summer Sale

Up to 30% off — ends 7 Aug

ONLY00h00m00s

Get 30% Off

Up to 30% off — ends 7 Aug

ONLY00h00m00s

Paul Hendrie

University of Washington

United States

This profile is automatically generated from trusted academic sources.

Google Scholar

ORCID

How do I reach out?

Meet Kite AI

Contact this professor

ORCID

Google Scholar

Research Interests

Internal Medicine

60%

Pharmacotherapy

40%

Oncology

60%

Hematology

50%

Oncology Nursing

30%

Inpatient Care

30%

Cancer Therapy

20%

Ask ApplyKite AI

Start chatting

How can you help me contact this professor?

What are this professor's research interests?

How should I write an email to this professor?

Articles10

Comparative analysis of infectious complications with outpatient vs. inpatient care for adults with high-risk myeloid neoplasm receiving intensive induction chemotherapy

Article Link

Year:

2021

Comparison of outpatient care following intensive induction versus post-remission chemotherapy for adults with acute myeloid leukemia and other high-grade myeloid neoplasms

Article Link

Year:

2021

Effect of post-treatment MRD status on subsequent outcomes according to chemotherapy intensity in acute myeloid leukemia (AML)

Article Link

Year:

2021

Survival of patients with newly diagnosed high-grade myeloid neoplasms who do not meet standard trial eligibility

Article Link

Year:

2021

Before the Flood

Article Link

Year:

2020

Early hospital discharge after intensive induction chemotherapy for adults with acute myeloid leukemia or other high-grade myeloid neoplasm

Article Link

Year:

2020

Erdheim-Chester disease: Consensus recommendations for evaluation, diagnosis, and treatment in the molecular era

Article Link

Year:

2020

Erdheim–Chester disease

Article Link

Year:

2020

Managing Cancer Care during the COVID-19 Pandemic: Agility and Collaboration Toward a Common Goal

Article Link

Year:

2020

Outpatient intensive induction chemotherapy for acute myeloid leukemia and high-risk myelodysplastic syndrome

Article Link

Year:

2020

Collaborators4

Oshrat Hershkovitz‐Rokah

ISRAEL

Matthew Collin

Professor of Haematology

Newcastle University

UNITED KINGDOM

Benjamin Durham

Assistant Professor, Tenure-Track

Rutgers Cancer Institute of New Jersey

UNITED STATES

Michael Hochman

Assistant Professor

Winship Cancer Institute

UNITED STATES

How do I reach out?

Meet Kite AI